ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Therapy for Inherited Genetic Disorders Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-8P14381
Home | Market Reports | Science| Biological Sciences
Global Gene Therapy for Inherited Genetic Disorders Market Research Report 2023
BUY CHAPTERS

Global Gene Therapy for Inherited Genetic Disorders Market Insights, Forecast to 2030

Code: QYRE-Auto-8P14381
Report
December 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BioMarin Pharmaceutical Inc
bluebird bio Inc
Novartis
Orchard Therapeutics plc.
Spark Therapeutics Inc

Gene Therapy for Inherited Genetic Disorders Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gene Therapy for Inherited Genetic Disorders Market

Gene Therapy for Inherited Genetic Disorders Market

In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.
Market Analysis and Insights: Global Gene Therapy for Inherited Genetic Disorders Market
The global Gene Therapy for Inherited Genetic Disorders market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Gene Therapy for Inherited Genetic Disorders market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Gene Therapy for Inherited Genetic Disorders, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gene Therapy for Inherited Genetic Disorders, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Therapy for Inherited Genetic Disorders revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Gene Therapy for Inherited Genetic Disorders market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Gene Therapy for Inherited Genetic Disorders revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Gene Therapy for Inherited Genetic Disorders Market Report

Report Metric Details
Report Name Gene Therapy for Inherited Genetic Disorders Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Research Institute
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BioMarin Pharmaceutical Inc., bluebird bio Inc., Novartis AG, Orchard Therapeutics Plc, Spark Therapeutics Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Gene Therapy for Inherited Genetic Disorders in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gene Therapy for Inherited Genetic Disorders companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy for Inherited Genetic Disorders revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Gene Therapy for Inherited Genetic Disorders Market report?

Ans: The main players in the Gene Therapy for Inherited Genetic Disorders Market are BioMarin Pharmaceutical Inc., bluebird bio Inc., Novartis AG, Orchard Therapeutics Plc, Spark Therapeutics Inc.

What are the Application segmentation covered in the Gene Therapy for Inherited Genetic Disorders Market report?

Ans: The Applications covered in the Gene Therapy for Inherited Genetic Disorders Market report are Hospital, Clinic, Research Institute, Others

What are the Type segmentation covered in the Gene Therapy for Inherited Genetic Disorders Market report?

Ans: The Types covered in the Gene Therapy for Inherited Genetic Disorders Market report are Eye Disorders, Hematological Disorders, Central Nervous System Disorders, Muscular Disorders, Others

Recommended Reports

Gene Therapy Markets

Genetic Diagnostics

Gene Therapy Tools

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Eye Disorders
1.2.3 Hematological Disorders
1.2.4 Central Nervous System Disorders
1.2.5 Muscular Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy for Inherited Genetic Disorders Market Perspective (2019-2030)
2.2 Global Gene Therapy for Inherited Genetic Disorders Growth Trends by Region
2.2.1 Gene Therapy for Inherited Genetic Disorders Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Therapy for Inherited Genetic Disorders Historic Market Size by Region (2019-2024)
2.2.3 Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Region (2025-2030)
2.3 Gene Therapy for Inherited Genetic Disorders Market Dynamics
2.3.1 Gene Therapy for Inherited Genetic Disorders Industry Trends
2.3.2 Gene Therapy for Inherited Genetic Disorders Market Drivers
2.3.3 Gene Therapy for Inherited Genetic Disorders Market Challenges
2.3.4 Gene Therapy for Inherited Genetic Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene Therapy for Inherited Genetic Disorders by Players
3.1.1 Global Gene Therapy for Inherited Genetic Disorders Revenue by Players (2019-2024)
3.1.2 Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Players (2019-2024)
3.2 Global Gene Therapy for Inherited Genetic Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Therapy for Inherited Genetic Disorders, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio
3.4.1 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Inherited Genetic Disorders Revenue in 2023
3.5 Global Key Players of Gene Therapy for Inherited Genetic Disorders Head office and Area Served
3.6 Global Key Players of Gene Therapy for Inherited Genetic Disorders, Product and Application
3.7 Global Key Players of Gene Therapy for Inherited Genetic Disorders, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy for Inherited Genetic Disorders Breakdown Data by Type
4.1 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Type (2019-2024)
4.2 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Type (2025-2030)
5 Gene Therapy for Inherited Genetic Disorders Breakdown Data by Application
5.1 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Application (2019-2024)
5.2 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Therapy for Inherited Genetic Disorders Market Size (2019-2030)
6.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type
6.2.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2019-2024)
6.2.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2025-2030)
6.2.3 North America Gene Therapy for Inherited Genetic Disorders Market Share by Type (2019-2030)
6.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application
6.3.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2024)
6.3.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2025-2030)
6.3.3 North America Gene Therapy for Inherited Genetic Disorders Market Share by Application (2019-2030)
6.4 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country
6.4.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2019-2024)
6.4.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size (2019-2030)
7.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type
7.2.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2019-2024)
7.2.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2025-2030)
7.2.3 Europe Gene Therapy for Inherited Genetic Disorders Market Share by Type (2019-2030)
7.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application
7.3.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2024)
7.3.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2025-2030)
7.3.3 Europe Gene Therapy for Inherited Genetic Disorders Market Share by Application (2019-2030)
7.4 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country
7.4.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2019-2024)
7.4.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene Therapy for Inherited Genetic Disorders Market Size (2019-2030)
8.2 China Gene Therapy for Inherited Genetic Disorders Market Size by Type
8.2.1 China Gene Therapy for Inherited Genetic Disorders Market Size by Type (2019-2024)
8.2.2 China Gene Therapy for Inherited Genetic Disorders Market Size by Type (2025-2030)
8.2.3 China Gene Therapy for Inherited Genetic Disorders Market Share by Type (2019-2030)
8.3 China Gene Therapy for Inherited Genetic Disorders Market Size by Application
8.3.1 China Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2024)
8.3.2 China Gene Therapy for Inherited Genetic Disorders Market Size by Application (2025-2030)
8.3.3 China Gene Therapy for Inherited Genetic Disorders Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Gene Therapy for Inherited Genetic Disorders Market Size (2019-2030)
9.2 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type
9.2.1 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type (2019-2024)
9.2.2 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type (2025-2030)
9.2.3 Asia Gene Therapy for Inherited Genetic Disorders Market Share by Type (2019-2030)
9.3 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application
9.3.1 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2024)
9.3.2 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application (2025-2030)
9.3.3 Asia Gene Therapy for Inherited Genetic Disorders Market Share by Application (2019-2030)
9.4 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Region
9.4.1 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Region (2019-2024)
9.4.3 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BioMarin Pharmaceutical Inc.
11.1.1 BioMarin Pharmaceutical Inc. Company Details
11.1.2 BioMarin Pharmaceutical Inc. Business Overview
11.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Introduction
11.1.4 BioMarin Pharmaceutical Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
11.1.5 BioMarin Pharmaceutical Inc. Recent Developments
11.2 bluebird bio Inc.
11.2.1 bluebird bio Inc. Company Details
11.2.2 bluebird bio Inc. Business Overview
11.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Introduction
11.2.4 bluebird bio Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
11.2.5 bluebird bio Inc. Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Introduction
11.3.4 Novartis AG Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
11.3.5 Novartis AG Recent Developments
11.4 Orchard Therapeutics Plc
11.4.1 Orchard Therapeutics Plc Company Details
11.4.2 Orchard Therapeutics Plc Business Overview
11.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Introduction
11.4.4 Orchard Therapeutics Plc Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
11.4.5 Orchard Therapeutics Plc Recent Developments
11.5 Spark Therapeutics Inc.
11.5.1 Spark Therapeutics Inc. Company Details
11.5.2 Spark Therapeutics Inc. Business Overview
11.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Introduction
11.5.4 Spark Therapeutics Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
11.5.5 Spark Therapeutics Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
BioMarin Pharmaceutical Inc
bluebird bio Inc
Novartis
Orchard Therapeutics plc.
Spark Therapeutics Inc
List of Tables
    Table 1. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Eye Disorders
    Table 3. Key Players of Hematological Disorders
    Table 4. Key Players of Central Nervous System Disorders
    Table 5. Key Players of Muscular Disorders
    Table 6. Key Players of Others
    Table 7. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Gene Therapy for Inherited Genetic Disorders Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Gene Therapy for Inherited Genetic Disorders Market Share by Region (2019-2024)
    Table 11. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Gene Therapy for Inherited Genetic Disorders Market Share by Region (2025-2030)
    Table 13. Gene Therapy for Inherited Genetic Disorders Market Trends
    Table 14. Gene Therapy for Inherited Genetic Disorders Market Drivers
    Table 15. Gene Therapy for Inherited Genetic Disorders Market Challenges
    Table 16. Gene Therapy for Inherited Genetic Disorders Market Restraints
    Table 17. Global Gene Therapy for Inherited Genetic Disorders Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Gene Therapy for Inherited Genetic Disorders Revenue Share by Players (2019-2024)
    Table 19. Global Top Gene Therapy for Inherited Genetic Disorders by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Inherited Genetic Disorders as of 2023)
    Table 20. Global Gene Therapy for Inherited Genetic Disorders Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Gene Therapy for Inherited Genetic Disorders Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Gene Therapy for Inherited Genetic Disorders, Headquarters and Area Served
    Table 23. Global Key Players of Gene Therapy for Inherited Genetic Disorders, Product and Application
    Table 24. Global Key Players of Gene Therapy for Inherited Genetic Disorders, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Gene Therapy for Inherited Genetic Disorders Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2019-2024)
    Table 28. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2025-2030)
    Table 30. Global Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Gene Therapy for Inherited Genetic Disorders Revenue Share by Application (2019-2024)
    Table 32. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Gene Therapy for Inherited Genetic Disorders Revenue Share by Application (2025-2030)
    Table 34. North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Gene Therapy for Inherited Genetic Disorders Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Gene Therapy for Inherited Genetic Disorders Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Gene Therapy for Inherited Genetic Disorders Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Gene Therapy for Inherited Genetic Disorders Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Gene Therapy for Inherited Genetic Disorders Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Gene Therapy for Inherited Genetic Disorders Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Gene Therapy for Inherited Genetic Disorders Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Gene Therapy for Inherited Genetic Disorders Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2025-2030) & (US$ Million)
    Table 66. BioMarin Pharmaceutical Inc. Company Details
    Table 67. BioMarin Pharmaceutical Inc. Business Overview
    Table 68. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product
    Table 69. BioMarin Pharmaceutical Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024) & (US$ Million)
    Table 70. BioMarin Pharmaceutical Inc. Recent Developments
    Table 71. bluebird bio Inc. Company Details
    Table 72. bluebird bio Inc. Business Overview
    Table 73. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product
    Table 74. bluebird bio Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024) & (US$ Million)
    Table 75. bluebird bio Inc. Recent Developments
    Table 76. Novartis AG Company Details
    Table 77. Novartis AG Business Overview
    Table 78. Novartis AG Gene Therapy for Inherited Genetic Disorders Product
    Table 79. Novartis AG Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024) & (US$ Million)
    Table 80. Novartis AG Recent Developments
    Table 81. Orchard Therapeutics Plc Company Details
    Table 82. Orchard Therapeutics Plc Business Overview
    Table 83. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product
    Table 84. Orchard Therapeutics Plc Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024) & (US$ Million)
    Table 85. Orchard Therapeutics Plc Recent Developments
    Table 86. Spark Therapeutics Inc. Company Details
    Table 87. Spark Therapeutics Inc. Business Overview
    Table 88. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product
    Table 89. Spark Therapeutics Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024) & (US$ Million)
    Table 90. Spark Therapeutics Inc. Recent Developments
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Gene Therapy for Inherited Genetic Disorders Market Share by Type: 2023 VS 2030
    Figure 3. Eye Disorders Features
    Figure 4. Hematological Disorders Features
    Figure 5. Central Nervous System Disorders Features
    Figure 6. Muscular Disorders Features
    Figure 7. Others Features
    Figure 8. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Gene Therapy for Inherited Genetic Disorders Market Share by Application: 2023 VS 2030
    Figure 10. Hospital Case Studies
    Figure 11. Clinic Case Studies
    Figure 12. Research Institute Case Studies
    Figure 13. Others Case Studies
    Figure 14. Gene Therapy for Inherited Genetic Disorders Report Years Considered
    Figure 15. Global Gene Therapy for Inherited Genetic Disorders Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Gene Therapy for Inherited Genetic Disorders Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Gene Therapy for Inherited Genetic Disorders Market Share by Region: 2023 VS 2030
    Figure 18. Global Gene Therapy for Inherited Genetic Disorders Market Share by Players in 2023
    Figure 19. Global Top Gene Therapy for Inherited Genetic Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Inherited Genetic Disorders as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Gene Therapy for Inherited Genetic Disorders Revenue in 2023
    Figure 21. North America Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Gene Therapy for Inherited Genetic Disorders Market Share by Type (2019-2030)
    Figure 23. North America Gene Therapy for Inherited Genetic Disorders Market Share by Application (2019-2030)
    Figure 24. North America Gene Therapy for Inherited Genetic Disorders Market Share by Country (2019-2030)
    Figure 25. United States Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Gene Therapy for Inherited Genetic Disorders Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Gene Therapy for Inherited Genetic Disorders Market Share by Type (2019-2030)
    Figure 29. Europe Gene Therapy for Inherited Genetic Disorders Market Share by Application (2019-2030)
    Figure 30. Europe Gene Therapy for Inherited Genetic Disorders Market Share by Country (2019-2030)
    Figure 31. Germany Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Gene Therapy for Inherited Genetic Disorders Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Gene Therapy for Inherited Genetic Disorders Market Share by Type (2019-2030)
    Figure 39. China Gene Therapy for Inherited Genetic Disorders Market Share by Application (2019-2030)
    Figure 40. Asia Gene Therapy for Inherited Genetic Disorders Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Gene Therapy for Inherited Genetic Disorders Market Share by Type (2019-2030)
    Figure 42. Asia Gene Therapy for Inherited Genetic Disorders Market Share by Application (2019-2030)
    Figure 43. Asia Gene Therapy for Inherited Genetic Disorders Market Share by Region (2019-2030)
    Figure 44. Japan Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Country (2019-2030)
    Figure 54. Brazil Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. BioMarin Pharmaceutical Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
    Figure 61. bluebird bio Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
    Figure 62. Novartis AG Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
    Figure 63. Orchard Therapeutics Plc Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
    Figure 64. Spark Therapeutics Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Human Gene Therapy Market Research Report 2025
Global Gene Therapy for CNS Disorders Market Research Report 2024
Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Gene Therapy For Cancer Market Research Report 2024
Global Gene Therapies for Cancer Treatment Market Research Report 2024
Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030
Gene Therapy in CNS Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Delivery or Gene Therapy Drug Market Research Report 2025
Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Genetic Modification Therapies Market Insights Forecast to 2030
Global Gene based Therapy Medicinal Market Research Report 2024
Global Gene based Advanced Therapy Medicinal Market Research Report 2025
Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Delivery System Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Cell and Gene Therapy Market Research Report 2024
Global Nucleic Acid Based Gene Therapy Market Research Report 2025
Gene Delivery System Technology Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy on Neurological Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions